Abstract

The OX40-OX40L pathway provides crucial co-stimulatory signals for CD4 T cell responses, however the precise cellular interactions critical for OX40L provision in vivo and when these occur, remains unclear. Here, we demonstrate that provision of OX40L by dendritic cells (DCs), but not T cells, B cells nor group 3 innate lymphoid cells (ILC3s), is critical specifically for the effector Th1 response to an acute systemic infection with Listeria monocytogenes (Lm). OX40L expression by DCs is regulated by cross-talk with NK cells, with IFNγ signalling to the DC to enhance OX40L in a mechanism conserved in both mouse and human DCs. Strikingly, DC expression of OX40L is redundant in a chronic intestinal Th1 response and expression by ILC3s is necessary. Collectively these data reveal tissue specific compartmentalisation of the cellular provision of OX40L and define a mechanism controlling DC expression of OX40L in vivo.

The OX40-OX40L axis is a crucial component of the costimulatory requirement of CD4 T cell responses. Here, the authors show context and cell type specific expression of OX40L for driving Th1 cell generation during acute and chronic models of infection.

Details

Title
Th1 responses in vivo require cell-specific provision of OX40L dictated by environmental cues
Author
Gajdasik, Dominika W 1 ; Fabrina, Gaspal 1 ; Halford, Emily E 1   VIAFID ORCID Logo  ; Fiancette Remi 1 ; Dutton, Emma E 1 ; Willis, Claire 1 ; Rückert Timo 2   VIAFID ORCID Logo  ; Romagnani Chiara 2   VIAFID ORCID Logo  ; Gerard, Audrey 3   VIAFID ORCID Logo  ; Bevington, Sarah L 4 ; MacDonald, Andrew S 5   VIAFID ORCID Logo  ; Botto, Marina 6   VIAFID ORCID Logo  ; Vyse, Timothy 7   VIAFID ORCID Logo  ; Withers, David R 1   VIAFID ORCID Logo 

 University of Birmingham, Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
 Charité - Universitätsmedizin Berlin, Med. Klinik m.S. Gastroenterologie, Infektiologie und Rheumatologie and Deutsches Rheuma-Forschungszentrum, Berlin, Germany (GRID:grid.6363.0) (ISNI:0000 0001 2218 4662) 
 The University of Oxford, The Kennedy Institute of Rheumatology, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 University of Birmingham, Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, Birmingham, UK (GRID:grid.6572.6) (ISNI:0000 0004 1936 7486) 
 University of Manchester, Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
 Imperial College London, Department of Medicine, Centre for Inflammatory Disease, London, UK (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111) 
 King’s College London, Division of Medical and Molecular Genetics and Immunology, Infection and Inflammatory Disease, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2421632294
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.